US pharma tariffs: Indian pharma packaging needs to weigh options

The Union Health Ministry held discussions last week, weighing options to safeguard the Indian pharmaceutical industry from potential tariffs that may be imposed by US president Donald Trump. Nine critical active pharmaceutical ingredients (APIs), or core medication compounds, were highlighted during the discussion.

by Prabhat Prakash